Single versus double autologous stem-cell transplantation for multiple myeloma.

Attal, Michel; Harousseau, Jean-Luc; Facon, Thierry; Guilhot, François; Doyen, Chantal; Fuzibet, Jean-Gabriel; Monconduit, Mathieu; Hulin, Cyrille; Caillot, Denis; Bouabdallah, Reda; Voillat, Laurent; Sotto, Jean-Jacques; Grosbois, Bernard; Bataille, Regis; Francophone du Myélome, InterGroupe

doi:10.1056/nejmoa032290

Public

Single versus double autologous stem-cell transplantation for multiple myeloma.

Shared by NobleBlocks on Dec 25, 2003 • 12:00 AM UTC

Authors:

Michel Attal

Jean-Luc Harousseau

Thierry Facon

Abstract

BACKGROUND: We conducted a randomized trial of the treatment of multiple myeloma with high-dose chemotherapy followed by either one or two successive autologous stem-cell transplantations. METHODS: At the time of diagnosis, 399 previously untreated patients under the age of 60 years were randomly as...

Discussions